Kevin O'Leary, a big-name investor known for his no-nonsense approach to business, has a unique strategy for dealing with ...

If you're a fan of the hit TV show “Pawn Stars,” you're probably familiar with Rick Harrison, the guy behind the Gold & ...

O’Leary took his mom's lesson to heart. He's known for his high-end wardrobe. He proudly showed off a $2,800 Yves Saint ...

Paramount, a new residential tower that rises 750 feet above the city, is poised to become Nashville's tallest building. The ...

The recent Federal Reserve rate cut has set the stage for potentially lower mortgage rates but industry experts are looking ...

DirecTV and Dish Network are in advanced talks to merge, potentially creating the largest U.S. pay-TV provider with 20 ...

Bristol Myers' Cobenfy, recently approved by the FDA for schizophrenia, lacks a boxed warning, positioning it as a safer ...

Nvidia Inc. (NASDAQ: NVDA) shares are trading lower Friday, along with the broader semiconductor sector, pulling back after a ...

J.B. Hunt shares rose 1.25% to $173.65 after announcing the addition of 20 Nikola Tre fuel cell electric vehicles to enhance ...

Acadia Healthcare has agreed to a $20 million settlement over allegations of false claims regarding unnecessary inpatient ...

Bristol Myers Squibb's Cobenfy has been approved by the FDA as the first new treatment for schizophrenia in decades. The ...

Just look at Andrew “Boz” Bosworth, Meta's CTO, the guy who invented Facebook's News Feed. Now, he's leading Meta's charge ...